208 related articles for article (PubMed ID: 24650300)
21. Symptomatic eosinophilic gastritis cured with Helicobacter pylori eradication.
Papadopoulos AA; Tzathas C; Polymeros D; Ladas SD
Gut; 2005 Dec; 54(12):1822. PubMed ID: 16284301
[No Abstract] [Full Text] [Related]
22. Culture and successful eradication of Helicobacter pylori from heterotopic gastric mucosa.
Wüppenhorst N; Viebahn B; Theile A; Radü HJ; Kist M
Z Gastroenterol; 2012 Jul; 50(7):677-9. PubMed ID: 22760679
[TBL] [Abstract][Full Text] [Related]
23. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
Savarino V; Mela GS; Zentilin P; Lapertosa G; Bisso G; Mele MR; Pivari M; Mansi C; Vigneri S; Celle G
Ital J Gastroenterol Hepatol; 1999; 31(1):4-8. PubMed ID: 10091096
[TBL] [Abstract][Full Text] [Related]
24. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
Kyzekova J; Mour J
Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
[TBL] [Abstract][Full Text] [Related]
25. [Eosinophilic gastroenteritis with ascites: clinical case report].
Yep Gamarra V; Matos Nova A; Aldave Herrera A
Rev Gastroenterol Peru; 2011; 31(2):173-7. PubMed ID: 21836658
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori eradication, endoscopic surveillance, and gastric cancer.
Cannizzaro R; De Paoli P
Am J Gastroenterol; 2009 Dec; 104(12):3100-1; author reply 3101-2. PubMed ID: 19956127
[No Abstract] [Full Text] [Related]
27. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
[TBL] [Abstract][Full Text] [Related]
28. [Clinical course of Helicobacter pylori associated chronic gastritis in post-eradicational period].
Livzan MA; Kononov AV; Mozgovoĭ SI
Eksp Klin Gastroenterol; 2007; (5):116-23, 165. PubMed ID: 18389608
[TBL] [Abstract][Full Text] [Related]
29. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
30. Primary eosinophilic gastroenteritis: A case series from western India.
Jadhav R; Khairnar H; Kolhe K; Chauhan SG; Walke S; Chaudhari V; Vishwanathan D; Pandey V; Ingle M
Indian J Gastroenterol; 2020 Aug; 39(4):411-414. PubMed ID: 32803717
[TBL] [Abstract][Full Text] [Related]
31. [Effect of H. pylori eradication regimes on the proliferation index of gastric mucosa].
Hep A; Zaloudík J; Janáková J; Habanec B; Prásek J; Dolina J; Dítĕ P
Vnitr Lek; 1998 Aug; 44(8):447-50. PubMed ID: 10358446
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
[TBL] [Abstract][Full Text] [Related]
33. [Helicobacter pylori: an etiologic factor in chronic gastritis, gastroduodenal ulcer and gastric cancer].
Ausina V
Med Clin (Barc); 1995 Nov; 105(15):576-9. PubMed ID: 7500677
[No Abstract] [Full Text] [Related]
34. Eosinophilic Gastroenteritis Presenting With Gastric Perforation.
Matsueda K; Toyokawa T
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):e31-e32. PubMed ID: 29366927
[No Abstract] [Full Text] [Related]
35. Granulomatous gastritis and Helicobacter pylori infection.
Delgado JS; Landa E; Ben-Dor D
Isr Med Assoc J; 2013 Jun; 15(6):317-8. PubMed ID: 23882902
[No Abstract] [Full Text] [Related]
36. Treatment of gastric marginal zone lymphoma of MALT type.
Stathis A; Bertoni F; Zucca E
Expert Opin Pharmacother; 2010 Sep; 11(13):2141-52. PubMed ID: 20586708
[TBL] [Abstract][Full Text] [Related]
37. OLGA can guard the barn.
Rugge M; de Boni M; Pennelli G; Mescoli C; Graham DY
Am J Gastroenterol; 2009 Dec; 104(12):3099; author reply 3101-2. PubMed ID: 19956125
[No Abstract] [Full Text] [Related]
38. The long-term effect of Helicobacter pylori eradication on COX-1/2, 5-LOX and leukotriene receptors in patients with a risk gastritis phenotype--a link to gastric carcinogenesis.
Venerito M; Kuester D; Wex T; Roessner A; Malfertheiner P; Treiber G
Cancer Lett; 2008 Nov; 270(2):218-28. PubMed ID: 18571838
[TBL] [Abstract][Full Text] [Related]
39. Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infection.
Miyake K; Tatsuguchi A; Suzuki K; Ueki N; Shinji Y; Kusunoki M; Iizumi T; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Tsukui T; Sakamoto C
Dig Liver Dis; 2005 Jun; 37(6):394-401. PubMed ID: 15893277
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial.
Xiao SD; Liu WZ; Xia DH; Jiang SJ; Wang RN; Zhang ZH; Xu WW
Hepatogastroenterology; 1990 Oct; 37(5):503-6. PubMed ID: 2253927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
